hi all just re-read the quarterly and noticed the responses to...

hi all
just re-read the quarterly and noticed the responses to part 8.6;

1. Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?
Answer: Cash will continue to diminish over time and will increase through fund raising via partnering and out licensing any of our current projects.
2. Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?
Answer: Despite the global impact of COVID-19 and the restrictions in New Zealand, business continues for LCT. We maintain contacts with the University of Auckland with regards to revised timelines for the obesity and migraine projects, which are dependent on the date the University reopens its laboratories. Our activities to pursue the next step for NTCELL® for Parkinson’s disease are also ongoing. We have initiated plans to raise cash in the next 12 months. We continue to seek partner and out licensing opportunities.
3. Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?
Answer: LCT continues to have sufficient cash to fulfil its current obligations; and in the next 12 months with cash in hand and by raising further funds.

The response to Question 1 advises that there will be funds gathered by out licensing or partnering. But the responses to Question 2 and 3 have advised that cash will be raised, although undetermined if through CR or other measure. While Q1 gave me a little optimism, Q2 & 3 quickly brought that back down.

Love to hear your thoughts